| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/25/1999 | WO1999008651A1 Skin care compositions and use |
| 02/25/1999 | WO1998053050A3 Short peptides which selectively modulate the activity of serine/threonine kinases |
| 02/25/1999 | WO1998052915A3 Leukotriene b4 derivatives, in particular oximo-ltb4 antagonists |
| 02/25/1999 | WO1998047866A3 Arylsecocholadiene derivatives |
| 02/25/1999 | DE19837386A1 New CCR-3 antagonist piperazine derivatives and analogues |
| 02/25/1999 | CA2301016A1 Use of 17-.alpha.-estradiol for the treatment of aged or sundamaged ski n and/or skin atrophy |
| 02/25/1999 | CA2300414A1 Enantiomers of 4-¬¬(cyanoimino)- ¬(1,2,2-trimethylpropyl) amino|methyl|amino| benzonitrile |
| 02/25/1999 | CA2300390A1 Human frezzled-like protein |
| 02/25/1999 | CA2298866A1 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 02/25/1999 | CA2296322A1 Preventives and/or remedies for systemic lupus erythematosus containing anti-il-6 receptor antibody as the active ingredient |
| 02/25/1999 | CA2241392A1 Pigr-2, a member of immunoglobulin gene superfamily |
| 02/25/1999 | CA2241390A1 Pigrl-1, a member of immunoglobulin gene superfamily |
| 02/24/1999 | EP0897981A1 Pigr-1, a member of immunoglobulin gene superfamily |
| 02/24/1999 | EP0897979A2 Human sdr2 cdna clone |
| 02/24/1999 | EP0897726A1 Antipruritic agent |
| 02/24/1999 | EP0897300A1 Treatment of pruritus with vitamin d and analogs thereof |
| 02/24/1999 | CN1208648A Chinese herb medicine allicin health-care liquid |
| 02/24/1999 | CN1042228C Antiallergic imidazoazepines |
| 02/24/1999 | CN1042226C Heterocyclic derivatives and method for preparing the salt thereof |
| 02/23/1999 | US5874573 Cyclic amine derivatives |
| 02/23/1999 | US5874080 Administering a therapeutic polypeptide antiallergens to inhabit elastase release by neutrophils |
| 02/23/1999 | US5874071 Antiodor, antimicrobial and preservative compositions and methods of using same |
| 02/23/1999 | CA2176255C Isoxazoline compounds as antiinflammatory agents |
| 02/23/1999 | CA1340401C Cell surface protein, process for its preparation, and the use of a cell surface protein thus obtained |
| 02/19/1999 | CA2240631A1 Pigr-1, a member of immunoglobulin gene superfamily |
| 02/18/1999 | WO1999007681A1 2-acylaminopropanamines as tachykinin receptor antagonists |
| 02/18/1999 | WO1999007407A1 Heparin-binding growth factor (hbgf) polypeptides |
| 02/18/1999 | WO1999007397A1 Use of polygonatum extracts for stimulating dermal elastin synthesis |
| 02/18/1999 | WO1999007396A1 Composition comprising propolis and at least an essential oil |
| 02/18/1999 | WO1999007362A1 A PROCESS FOR STABIlIZING LEVOGYRE ASCORBIC ACID (LAA) AND STABLE LAA COMPOSITIONS |
| 02/18/1999 | WO1999007351A2 Indole derivatives and their use as mcp-1 antagonists |
| 02/18/1999 | WO1999007338A1 USE OF THE Rb1 GINSENOSIDE FOR STIMULATING ELASTIN SYNTHESIS |
| 02/18/1999 | WO1999007337A1 Use of a 2-amino-alkane polyol as agent for treating skin ageing signs |
| 02/18/1999 | DE19736265A1 Medicament containing salicyl alcohol and maleic or fumaric acid |
| 02/18/1999 | CA2301068A1 Composition comprising propolis and at least an essential oil |
| 02/18/1999 | CA2299411A1 Heparin-binding growth factor (hbgf) polypeptides |
| 02/18/1999 | CA2299171A1 Use of a 2-amino-alkane polyol as agent for treating skin ageing signs |
| 02/18/1999 | CA2298702A1 2-acylaminopropanamines as tachykinin receptor antagonists |
| 02/18/1999 | CA2297290A1 Chemical compounds |
| 02/18/1999 | CA2268030A1 A process for stabilizing levogyre ascorbic acid (laa) and stable laa compositions |
| 02/18/1999 | CA2245043A1 Ccr-3 receptor antagonists |
| 02/18/1999 | CA2245041A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists |
| 02/17/1999 | EP0897011A2 Novel arginine deiminase |
| 02/17/1999 | EP0897008A2 His5 |
| 02/17/1999 | EP0896622A1 Chemokine alpha 2 |
| 02/17/1999 | EP0896537A1 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide |
| 02/17/1999 | EP0896522A1 Methods of regulating skin appearance with vitamin b 3? compound |
| 02/17/1999 | EP0896521A1 Composition, barrier film, and method for preventing contact dermatitis |
| 02/17/1999 | EP0633774B1 Topical administration of toremifene and its metabolites |
| 02/17/1999 | CN1208418A Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |
| 02/17/1999 | CN1208417A Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 02/17/1999 | CN1208412A Antagonists of gonadotropin releasing hormone |
| 02/17/1999 | CN1208034A Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 02/17/1999 | CN1207939A Chinese medicine oil preparation for burns and scalds and its preparation |
| 02/17/1999 | CN1207936A Beriberi medicine liquid and its preparation |
| 02/17/1999 | CN1207903A Chinese medicine preparation for skin diseases |
| 02/17/1999 | CN1207901A External-use Chinese medicine |
| 02/16/1999 | US5872149 Alk(en)yldicarboxylic acid bisesters, their use, and processes for their preparation |
| 02/16/1999 | US5872140 Vitamin D analogues |
| 02/16/1999 | US5872114 Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 02/16/1999 | US5872112 Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
| 02/16/1999 | US5871998 Gene expression in transformed eukaryotic host cell; genetic engineering |
| 02/16/1999 | US5871950 Methods of treating autoimmune diseases and transplantation rejection |
| 02/16/1999 | US5871729 Superoxide dismutase-4 |
| 02/16/1999 | CA2162329C Novel solar screens, cosmetic ultraviolet-protecting compositions containing the same and their use |
| 02/13/1999 | CA2240637A1 Novel ratb |
| 02/12/1999 | CA2239835A1 Human sdr2 cdna clone |
| 02/11/1999 | WO1999006540A2 Inhibitors of cell-cycle progression and uses related thereto |
| 02/11/1999 | WO1999006434A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006433A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006423A1 83 human secreted proteins |
| 02/11/1999 | WO1999006404A1 1,2,4-triazolo[4,3-b]pyrido[3,2-d]pyridazine derivatives and pharmaceutical compositions containing them |
| 02/11/1999 | WO1999006391A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof |
| 02/11/1999 | WO1999006390A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006354A1 Il-8 receptor antagonists |
| 02/11/1999 | WO1999006340A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 02/11/1999 | WO1999006056A1 Use of physiologically acceptable vanadium compounds, salts and complexes |
| 02/11/1999 | WO1999006050A1 Remedial agent for baldness and other diseases |
| 02/11/1999 | WO1999006036A1 Use of selective rxr agonists to prevent surgical adhesions |
| 02/11/1999 | WO1999006025A1 Method and compositions for treating late phase allergic reactions and inflammatory diseases |
| 02/11/1999 | WO1999006020A1 Skin whitener composition containing mercaptodextran |
| 02/11/1999 | WO1999006019A1 Anti-desquamative cosmetic composition and method for making said composition |
| 02/11/1999 | WO1998050000A3 Cosmetic particulate gel carriers for topically applied active agents |
| 02/11/1999 | CA2298935A1 1,2,4-triazolo[4,3-b]pyrido[3,2-d]pyridazine derivatives and pharmaceutical compositions containing them |
| 02/11/1999 | CA2298852A1 83 human secreted proteins |
| 02/11/1999 | CA2298851A1 Remedial agent for baldness and other diseases |
| 02/11/1999 | CA2298617A1 Acyclic metalloprotease inhibitors |
| 02/11/1999 | CA2298115A1 Inhibitors of cell-cycle progression and uses related thereto |
| 02/11/1999 | CA2295807A1 Use of selective rxr agonists to prevent surgical adhesions |
| 02/11/1999 | CA2294064A1 Il-8 receptor antagonists |
| 02/11/1999 | CA2290750A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2290746A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2239836A1 Novel arginine deiminase |
| 02/11/1999 | CA2239813A1 Novel nrdd |
| 02/11/1999 | CA2239221A1 Novel his5 |
| 02/10/1999 | EP0895478A1 Component b as cicatrizant |
| 02/10/1999 | EP0752878A4 Products comprising substrates capable of enzymatic cross-linking |
| 02/10/1999 | EP0710239B1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 02/10/1999 | CN1207743A Inhibitors of interleukin-1 'beta' converting enzyme |
| 02/10/1999 | CN1207741A Synthetic metal-substituted bacteriochlorophyll derivs. and use thereof |